Hydroxycut Advanced Non-Stimulant caplet
Natural health product licensed in Canada
- Other names
- Hydroxycut Advanced Non-Stimulant, Hydroxycut Pro Clinical Non-Stimulant
- Licence holder
- Iovate Health Sciences International Inc.
- NPN or DIN-HM
- 80038907
- Status
- Active licence
- Licence date
- 21 January 2013
- Revision date
- 30 May 2019
- Form
- Caplet
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Hyssopus officinalis L.: L'huile essentielle de cette plante est interdite.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Thiamine Source : Thiamine HCl | 0.75 mg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 0.5 mg | Not calculated |
| Passiflora incarnata Source : Fleur | 25 mg | Not calculated |
| Riboflavine Source : Riboflavine | 0.85 mg | Not calculated |
| Vitamine B12 Source : Cyanocobalamine | 0.6 mcg | Not calculated |
| Hyssopus officinalis Source : Plante | 5 mg | Not calculated |
Non-medicinal ingredients
Carboxyméthylcellulose de sodium, Poly(alcool vinylique), Acide stéarique, Dioxyde de titane, Dicalcium Phosphate Anhydrous, Talc, Hydroxypropylcellulose, Stéarate de magnésium, silice, Microcrystalline cellulose, Crospovidone, Poly(éthylène glycol), Acesulfame Potassium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Caplet | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Could be a complement to a healthy lifestyle that incorporates a calorie-reduced diet and regular physical activity for individuals involved in a weight management program. Helps support heart/cardiovascular health. Maintains healthy blood pressure. Helps the body to metabolize carbohydrates, fats and proteins.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80038907
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Passiflora incarnata
Read the warning, when it applies and the studies cited
PASSIONFLOWER -PASSIFLORA INCARNATA
Route of administration: Oral
Cautions and warnings
Condition of application: Sleep aid.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if sleeplessness persists for more than 4 weeks (chronic insomnia) (Berardi et al. 2002: DiPiro et al. 2002).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All uses.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2014).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product avoid taking with alcohol or products that cause drowsiness (EMA 2014; Brinker 2010).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (EMA 2014).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (EMA 2014).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
- Hyssopus officinalis
Read the warning, when it applies and the studies cited
Hyssop - Hyssop Officinalis
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Contraindications
Do not use if you are pregnant (Gardner and McGuffin 2013; Bradley 2006).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.